Immutep (IMMP) Exchange Rate Effect (2016 - 2024)
Immutep (IMMP) posted Exchange Rate Effect of -$186541.5 for Q2 2024, up 5.72% on a QoQ basis from -$197860.1 in Q2 2023, and up 5.72% year-over-year from -$176447.8 in Q3 2023.
Immutep (IMMP) Exchange Rate Effect (2016 - 2024) Analysis & Trends
Immutep's Exchange Rate Effect history runs 4 years deep, the most recent figure standing at -$186541.5 for Q2 2024.
- Quarterly Exchange Rate Effect rose 5.72% year-over-year to -$186541.5 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was -$49977.7 (changed N/A YoY) and the FY2025 annual result came in at $4.3 million, up 775.43% from the prior year.
- Exchange Rate Effect was -$186541.5 for Q2 2024 at Immutep, up from -$197860.1 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at -$186541.5 in Q2 2024 and bottomed at -$197860.1 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Immutep | 569.08 Mn | 569.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -186,541.49 |
| Jun 30, 2024 | -186,541.49 |
| Jun 30, 2023 | -197,860.09 |
| Jun 30, 2023 | -197,860.09 |
| Jun 30, 2017 | 407,726.92 |
| Jun 30, 2017 | 407,726.92 |
| Jun 30, 2016 | -73,303.03 |
| Jun 30, 2016 | -73,303.03 |